microRNAs in glomerular diseases from pathophysiology to potential treatment target (Q38424330)

3 September 2017

1 reference

title

microRNAs in glomerular diseases from pathophysiology to potential treatment target (English)

1 reference

3 September 2017

1 reference

Fabio Sallustio

2

1 reference

ORCID Public Data File 2021

Grazia Serino

object named as

Grazia Serino

series ordinal

3

1 reference

ORCID Public Data File 2021

author name string

Francesco P Schena

series ordinal

1

1 reference

PubMed ID

25881669

3 September 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

3 September 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

Clinical Science

1 reference

3 September 2017

128

1 reference

3 September 2017

775-788

1 reference

3 September 2017

11

1 reference

How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?

3 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

CKD273, a new proteomics classifier assessing CKD and its prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Review: The role of microRNAs in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

The long and short of microRNAs in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNAs in kidney disease: an emerging understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNAs as regulators of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Expression of microRNAs in the urinary sediment of patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Serum microRNAs levels in primary focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Identification of unique microRNA signature associated with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Serum and urinary free microRNA level in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Circulating microRNA expression profiles associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140733

21 January 2018

Identifiers

DOI

10.1042/CS20140733

1 reference

3 September 2017

1 reference

PubMed ID

25881669